500 related articles for article (PubMed ID: 22155216)
1. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
[TBL] [Abstract][Full Text] [Related]
3. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
Santiveri CM; Sborgi L; de Alba E
J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
[TBL] [Abstract][Full Text] [Related]
4. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
5. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
6. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
7. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
Zhang S; Long A; Link AJ
ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.
Zheng CH; Yang H; Zhang M; Lu SH; Shi D; Wang J; Chen XH; Ren XH; Liu J; Lv JG; Zhu J; Zhou YJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):39-44. PubMed ID: 22172701
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and helical structure of lactam bridged BH3 peptides derived from pro-apoptotic Bcl-2 family proteins.
Yang B; Liu D; Huang Z
Bioorg Med Chem Lett; 2004 Mar; 14(6):1403-6. PubMed ID: 15006371
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
[TBL] [Abstract][Full Text] [Related]
11. Robust lanthanide-based assays for the detection of anti-apoptotic Bcl-2-family protein antagonists.
Rega MF; Reed JC; Pellecchia M
Bioorg Chem; 2007 Apr; 35(2):113-20. PubMed ID: 16996562
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics study of segment peptides of Bax, Bim, and Mcl-1 BH3 domain of the apoptosis-regulating proteins bound to the anti-apoptotic Mcl-1 protein.
Zhao RN; Fan S; Han JG; Liu G
J Biomol Struct Dyn; 2015; 33(5):1067-81. PubMed ID: 24865469
[TBL] [Abstract][Full Text] [Related]
14. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
[TBL] [Abstract][Full Text] [Related]
15. Interaction of E1B 19K with Bax is required to block Bax-induced loss of mitochondrial membrane potential and apoptosis.
Han J; Modha D; White E
Oncogene; 1998 Dec; 17(23):2993-3005. PubMed ID: 9881701
[TBL] [Abstract][Full Text] [Related]
16. Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70.
Sawada M; Hayes P; Matsuyama S
Nat Cell Biol; 2003 Apr; 5(4):352-7. PubMed ID: 12652309
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
Lama D; Sankararamakrishnan R
J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
[TBL] [Abstract][Full Text] [Related]
18. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
19. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
Mei Y; Du W; Yang Y; Wu M
Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the anti-apoptotic mechanism of Bcl-B.
Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]